Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Enhanced lymphatic exposure of a chemotherapeutic drug with pegylated, nano-sized drug vectors

  • In: SUBMITTED ORALS on Tuesday, 15 April 2014, 16:00-17:30
  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Presentation
  • By: RYAN, Gemma (Monash University, Pharmaceutics, Melbourne, Australia)
  • Co-author(s): Kaminskas, Lisa (Monash University, Melbourne, Australia)
    Bulitta, J (Monash University, Melbourne, Australia)
    Michelle, Mcintosh (Monash University, Melbourne, Australia)
    Owen, David (Starpharma Pty Ltd, Melbourne, Australia)
    Porter, Chris (Monash University, Melbourne, Australia)
  • Abstract:

    I. Background: The treatment of lymph-resident cancers presents a challenge, since small molecule chemotherapeutic drugs typically have limited lymphatic access. Nano-sized drug carriers can improve lymphatic drug targeting, although to this point, it is not known which drug carriers optimally increase lymphatic exposure.
    II. Aims: To assess the..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses